Article Figures & Data
Figures
- Figure 1.
HbA1c Change From Baseline at Week 26
LSM, least squares mean.
aTreatment difference (nominal 95%) CI, mixed-model repeated-measures analysis.
Reprinted from The Lancet, 384, Dungan KM, Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial, 1349–1357, Copyright 2014, with permission from Elsevier.
- Figure 2.
Body Weight Change Throughout Time
LSM, least squares mean.
* P < .05.
Reprinted from The Lancet, 384, Dungan KM, Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial, 1349–1357, Copyright 2014, with permission from Elsevier.
Tools
Dulaglutide Noninferior to Liraglutide for Glycemic Control in Patients with T2DM
Permalink:
Table of contents
Cited By...
- No citing articles found.